Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women.
about
Neoadjuvant cisplatin for advanced bladder cancerChemotherapy, radiotherapy and combined modality for Hodgkin's disease, with emphasis on second cancer riskTamoxifen: catalyst for the change to targeted therapyAn historical perspective on meta-analysis: dealing quantitatively with varying study resultsEndocrinology and hormone therapy in breast cancer: endocrine therapy in premenopausal womenHas tamoxifen had its day?Clinical trial update: International Breast Cancer Study GroupTamoxifen may prevent both ER+ and ER- breast cancers and select for ER- carcinogenesis: an alternative hypothesis.Progress in adjuvant chemotherapy for breast cancer: an overviewMeta-analysis: some clinical and statistical contributions in several medical disciplinesEndometrial lesions in patients undergoing tamoxifen therapyIGF status is altered by tamoxifen in patients with breast cancer.Tamoxifen and risk of idiopathic venous thromboembolismMolecular mechanisms and treatment of bone metastasis.To IPD or not to IPD? Advantages and disadvantages of systematic reviews using individual patient data.Meta-analysis of individual patient data from randomized trials: a review of methods used in practice.Population-based assessment of hospitalizations for toxicity from chemotherapy in older women with breast cancerAssessing the clinical impact of prognostic factors: when is "statistically significant" clinically useful?Novel drugs that target the estrogen-related receptor alpha: their therapeutic potential in breast cancerStatus of adjuvant endocrine therapy for breast cancer.Effect of SERMs on breast tissue.Modern mammography screening and breast cancer mortality: population studyOvarian ablation in breast cancer, 1896 to 1998: milestones along hierarchy of evidence from case report to Cochrane review.Survival and reduction in mortality from breast cancer. Impact of mammographic screening is not clear.Altering the estrogenic milieu of breast cancer with a focus on the new aromatase inhibitors.Neoadjuvant cisplatin for advanced bladder cancer.Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93Current and future directions in medical therapy for breast carcinoma: endocrine treatment.Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality databaseBreast Cancer Guidelines in Canada: A Review of Development and Implementation.Selective estrogen receptor modulators: tissue specificity and clinical utility.MRI: a role in clinical trials.From adjuvant therapy to breast cancer prevention: BCPT and STAR.Two-stage meta-analysis of survival data from individual participants using percentile ratios.Treatment of recurrent spontaneous abortion by immunization with paternal lymphocytes: results of a controlled trial.Testing for HER2 in Breast Cancer: A Continuing Evolution.Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial.Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer.Expression of cyclin kinase subunit 2 in human breast cancer and its prognostic significance.Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial
P2860
Q24236721-FFD95B69-D207-4BBE-B992-DFAEFEB0F153Q24245375-90867C66-A5D3-4D97-A3ED-5F5AE044E0D5Q24652988-A8FEC56B-4480-48F9-AFFF-D830A3A60F1EQ24670361-68A8DE95-2873-4828-9CEE-1EF90F4F4832Q24797219-2DD4AA7C-CF07-41B1-AEEB-634A1F2164FBQ24800161-09428C97-82F2-4640-B3F5-12E58BDEF813Q25257838-DAFFA19E-4DA7-4A82-ABE5-5503D24DFD81Q25257858-56CD8F79-E123-4A08-A7F8-218CF64B65B3Q26798078-CE6591B8-EAC7-4896-AD96-6480A52AAC8BQ28222536-5CAF1329-4B1E-4F5F-9AF5-E0159C109290Q28323079-9A273510-A2B9-4567-B306-1BC3ABA4C39AQ28360503-5DB81C2E-5D66-41C7-A6A0-4B8CC4046901Q28368257-39862F62-6473-4D1A-9572-0527933B3249Q30445717-454BC0AB-15A3-4739-88B9-DA0953801272Q30676636-3E09AA6B-90DC-4260-9E8B-000C443F678DQ31016826-50D7D962-336D-40ED-95F8-444EF215F44DQ33345743-65D6EE3E-EAC9-4C1C-BA18-836FE0B8D0D0Q33538461-F305F59F-C42F-4F09-87F5-686D7FA696E3Q33698278-A110A680-FE7E-4D60-A56D-E7977AEF0F39Q33739138-CFB4879F-443C-40B2-8CAB-79B5468ACAEAQ33757750-A1291E65-E93B-4524-B855-4FF2B34E4D82Q33770344-43827A25-E36C-488A-AB9C-516797616EF2Q33792412-437BE610-8FA9-45AC-8F64-16886DB60DF6Q33803281-C8692548-95DB-42AE-96D7-EAF77EFFC570Q33871478-3EAEEAE0-D25B-4091-8357-6A72B52BEE5AQ33909835-ACC2B0CE-A91B-407F-B820-AEE322DDB1A6Q33966418-43849CB3-2C5B-477D-AE76-314D3D0A8564Q33970582-1FFDAE26-3677-4457-9765-59044C329307Q34061266-DF076FDD-7B39-4CE8-85D5-3F7E95BD3DC6Q34096192-18EE2FF5-E826-4504-95E3-136A62358EB8Q34134828-701CECD0-3C57-4213-B6C7-05C6B74C4191Q34267801-2ECB90D5-A659-4347-9888-2306DD7D5834Q34317586-FDDA96C9-0203-42C2-A4DB-898C2D7541D3Q34349070-6CEA2878-1D27-4302-A888-AC1324B4562FQ34351129-8C9F2CAB-0FA9-46FD-B197-39C168332DAEQ34424285-1D2EA5F5-80EF-4B75-87AC-2E02E6D74F4DQ34478845-068A745B-52BB-439B-8EAC-4C4EA9BCE1D7Q34601123-489A8C76-D7E5-4B56-9B70-75AA4A6BCBAEQ35038513-D69CAEBB-FD60-4FDC-86C2-F474D847B5DEQ35119211-9F450011-4CFC-43F3-8683-59FD8AB3099C
P2860
Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh-hant
name
Effects of adjuvant tamoxifen ...... zed trials among 28,896 women.
@en
Effects of adjuvant tamoxifen ...... zed trials among 28,896 women.
@nl
type
label
Effects of adjuvant tamoxifen ...... zed trials among 28,896 women.
@en
Effects of adjuvant tamoxifen ...... zed trials among 28,896 women.
@nl
prefLabel
Effects of adjuvant tamoxifen ...... zed trials among 28,896 women.
@en
Effects of adjuvant tamoxifen ...... zed trials among 28,896 women.
@nl
P1476
Effects of adjuvant tamoxifen ...... zed trials among 28,896 women.
@en
P2093
Early Breast Cancer Trialists' Collaborative Group
P304
P356
10.1056/NEJM198812293192601
P407
P577
1988-12-01T00:00:00Z